Bioventus makes pain treatment and surgical products for musculoskeletal care, sold to physicians, surgeons and hospitals. BVS reports earnings on Mon, Nov 2, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 17 | Canaccord Genuity | Target raised | Buy | |
| Aug 17 | Cantor Fitzgerald | Reiterated | Buy | |
| Jun 30 | Barrington Research | Maintained | Buy | |
| Jun 16 | Canaccord Genuity | Maintained | Buy | |
| May 22 | Barrington Research | Maintained | Buy |
Seasonality
How BVS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
Whale Options Flow
90DNo whale options trades in BVS in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BVS is in one of them and how their past BVS trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered BVS in an article yet. Here's the latest on the wider market.
About Bioventus
Bioventus is a medical device company based in Durham, North Carolina. It makes products that relieve pain and treat musculoskeletal conditions, including hyaluronic acid knee injections, implantable nerve stimulation systems for chronic pain, and ultrasonic bone cutting tools used in spine and neurosurgery. The company also offers bone graft substitutes that support bone fusion and a device that uses low intensity pulse ultrasound to help fractures heal. Its customers include physicians and surgeons, along with the hospitals, clinics and ambulatory surgical centers where patients are treated.
- Headquarters
- Durham, NC